AltheaDx

Founded in 2002, CELPROGEN is a biotechnology company, with over 5000 products in the market, focused on developing stem cell research and therapeutics products for regenerative medicine in cardiology, oncology, diabetes & neurology. All of Celprogen’s biological products, including stem cells, cancer stem cells, iPC’s & media with specific ECM’s, are manufactured and produced in the United States of America.

CELPROGEN provides novel molecular diagnostics and therapeutic product development solutions for Biotechnology, Pharmaceutical, In-vitro diagnostics and academic partnership for drug discovery.

It has 3 divisions:

• Therapeutic Division: Focused on Drug Discovery efforts to develop Pharmaceutical agents and Drugs in the following categories: Cardiovascular, Diabetes, Neurological, Oncology,Renal and Metabolic disorders.
• Life Science Division: Provides research tools & solutions for assays, enzymes, antibodies, antigens, stem cells, Tissue culture expansion and differentiation media, primary and established cell cultures, tumor markers, cardiac markers, proteomic and genomic reagents and assay systems for life science academic and pharmaceutical communities.
• Device Division: Provides novel ELISA based assay, protein array, DNA array and cellular based assay systems that are cost effective for Research and In-vitro diagnostics Industries.

CH3 BioSystems LLC is a biotechnology company organized around intellectual property created through research in chemical biology and epigenetics. The products derived from this research enable our end users, Biologists, Chemists and Clinicians, to create new diagnostics and potential therapeutic treatments for human and animal diseases. We manufacturer molecular tools for faster, more efficient and safer methods to facilitate research discoveries.

Our patented CH3 antibody and other IP protected products provide scientists with a novel molecular toolkit to study protein methylation status in diseases like cancer, HIV and neurodevelopmental, autoimmune or cardiovascular disordered.

Our vision is to promote the growth of the field of protein methylation biology and to provide cutting edge clinically relevant pharmaceutical products of the 21st century.

Invivotek LLC, a member of Genesis Biotechnology Group® (GBG) is a global pre-clinical contract research organization (CRO) specializing in small animal studies for drug discovery and early optimization. Invivotek's facility was opened in 2012 and our first commercial project launched in 2013.

Invivotek offers both custom and standard pre-clinical services for drug discovery and development programs for our clients. Invivotek’s portfolio includes animal models and bioassays designed to support in vivo testing of compounds related to Immunology and Inflammation, Oncology, Metabolic, and Cardiovascular diseases. Invivotek’s in vivo testing capabilities are supported by biochemical and molecular biology techniques as well as functional assays with primary cell cultures established from various mouse tissues under disease model and normal conditions. These assays provide tools to study the mechanism of action of various test therapeutics or potential target genes and to explore drug efficacy biomarkers. The collective experience across multiple therapeutic areas in conjunction with the business and project management skills of the team working in a state-of-the-art animal facility, position Invivotek as a leading provider of preclinical in vivo services.

Amarex is a global, full-service Contract Research Organization (CRO), whose leadership team has significant expertise conducting biomedical research, and whose combined experience includes the design and conduct of several hundred clinical research projects in many therapeutic indications. Amarex provides comprehensive services in Project Management (Phase I-IV, BE/BA, PK/PD), Regulatory Affairs (FDA Applications and meetings, Applications to International Health Authorities, GxP Compliance Audits), Clinical Operations, Adaptive Study Designs, Statistical Analysis, Data Management, Medical Monitoring, Safety and Pharmacovigilance, and General Consulting. Amarex can take your product through the entire approval process, from creating the regulatory approval strategy, to conducting trials, to writing the marketing approval application. Join our growing list of clients with approved products. Amarex provides high quality and cost efficient services.

Sign-up to receive invites to webinars, training courses and the latest cutting-edge information on clinical trials: https://go.pardot.com/l/129231/2020-07-27/39ng9k

Founded in 1989 by the University of Colorado, CPC has two divisions. CPC Clinical Research is an academically led, non-profit, clinical research organization offering Phase 1 - 4 clinical research leadership and management services to sponsors around the world. CPC Clinical Research specializes in innovative research including a proprietary program, the Endpoint Quality Intervention Program (EQuIP), that helps reduce variability in the collection of endpoint data, allowing more definitive answers to the study objectives.

CPC Community Health creates innovative and educational programs to implement established cardiovascular prevention national guidelines and best evidence in Colorado communities resulting in improved cardiovascular health.

CPC is affiliated with the University Of Colorado School Of Medicine, Denver Health and the National Jewish Health. CPC is also the clinical trials arm of the University of Colorado Charles C Gates Center for Regenerative Medicine & Stem Cell Biology whose goal is to understand the biology of stem cells in order to develop new therapies for debilitating diseases such as heart diseases and vascular diseases.

CPC CLINICAL RESEARCH MISSION

To unite academic leadership with operational expertise to optimize the quality of clinical research and improve health.

CPC COMMUNITY HEALTH MISSION

Our mission is to improve the health of all Coloradans by creating innovative community health programs that deliver evidence-based interventions.

Visit us at www.cpcmed.org and www.communityhealth.org